Options
- Stimulate insulin release (sulphonylureas) e.g. glicazide
- Improve tissue utilisation of glucose (biguanides) e.g. metformin
- increase renal excretion of glucose (SGLT2 inhibtors) e.g. dapaglifozin
- alter GIT absorption of CHO (Alpha-glucosidase inhibitors) e.g. acarbose
- exogenous insulin
Type II Diabetes (insulin resistance predominates)
- Lifestyle change
- Oral medication
- Insulin (if above inadequate to attain BSL control)
Type I Diabetes (insulin deficiency)
- Lifestyle change
- Insulin
Further reading: Australian Therapeutic Guidelines (for specific regimes)